業績｜論文・出版物｜目次｜

2017

Highly efficient biallelic genome editing of human ES/iPS cells Using a CRISPR/Cas9 or TALEN system

Takayama K., Igai K., Hagihara Y., Hashimoto R., Hanawa M., Sakuma T., Tachibana M., Sakurai F., Yamamoto T., Mizuguchi H.

Nuc. Acid Res., 45, 5198-5207 (2017)

Type I interferons impede short-hairpin RNA-mediated RNA interference via inhibition of dicer-mediated processing to small interfering RNA

Machitani M.#, Sakurai F.#, Wakabayashi K., Takayama K., Tachibana M., Mizuguchi H. #These authors equally contributed to this work.

Mol. Ther. Nucleic Acids, 6, 173-182 (2017)

Hepatocyte Nuclear Factor 4 alpha promotes definitive endoderm differentiation from human induced pluripotent stem cells

Hanawa M., Takayama K., Sakurai F., Tachibana M., Mizuguchi H.

Stem Cell Rev., 13, 542-551 (2017)

Generation of human pluripotent stem cell-derived hepatocyte-like cells for drug toxicity screening

Takayama K., Mizuguchi H.

Drug Metab. Pharmacokinet., 32, 12-20 (2017)

zone特異的性質を有するヒトES/iPS細胞由来肝細胞の作製法の開発

三谷成二, 高山和雄, 水口裕之

肝細胞研究会HP・研究交流 (2017)

大阪大学大学院薬学研究科分子生物学分野